Molecular Glue Degraders (MGDs) – From the Bench to the Clinic
Time: 10:00 am
day: Day Two AM
Details:
- MGDs discovered serendipitously have been limited in scope to heme oncology
- Monte Rosa’s Queen™ platform allows identification of highly selective and oral MGDs that go beyond heme oncology into solid tumors and non-oncology indications, as illustrated by our GSPT1 and VAV1 programs